Anacetrapib

Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the scrap heap
Endpoints
Wed, 10/11/17 - 11:05 pm
Merck
Anacetrapib
clinical trials
CETP inhibitors
Will Merck Seek FDA Filing For Heart Drug After Lackluster Results?
Xconomy
Tue, 08/29/17 - 11:24 am
Merck
FDA
Anacetrapib
CETP inhibitors
Drugmakers face challenges marketing new heart drugs
Medical Marketing and Media
Sat, 07/22/17 - 10:01 am
drug marketing
Amgen
Repatha
Novartis
Entresto
Ilaris
canakinumab
Merck
Anacetrapib
Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed
Forbes
Tue, 06/27/17 - 11:01 am
Merck
Anacetrapib
cholesterol
clinical trials
Merck Awaits News On Free Win With High Risk Heart Drug
Seeking Alpha
Sun, 01/22/17 - 01:33 pm
Merck
Anacetrapib
Panel recommends Merck continue cholesterol drug study
Yahoo/Reuters
Fri, 11/13/15 - 10:03 am
FDA
advisory panels
Merck
Anacetrapib
Merck’s CETP inhibitor seems to have very low chances of success after Eli Lilly’s similar drug failed in its late stages
Bidness, ETC
Thu, 10/15/15 - 09:41 am
Merck
Eli Lilly
CETP inhibitors
Anacetrapib
evacetrapib
Merck cholesterol drug's odds dim after Lilly failure
Yahoo/Reuters
Tue, 10/13/15 - 09:48 am
Merck
Eli Lilly
Anacetrapib
evacetrapib
Forget HDL, Merck Is Banking On LDL For Its Heart Drug, Anacetrapib
Forbes
Thu, 02/5/15 - 05:13 pm
Merck
LDL cholesterol
Anacetrapib
Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug?
Forbes
Fri, 11/21/14 - 10:26 am
Anacetrapib
Merck
IMPROVE-IT
Merck Heart Drug Runs Into New Worry
Forbes
Tue, 10/22/13 - 04:59 pm
Merck
Anacetrapib
The Big Gamble of CETP Inhibitors Comment Now Follow Comments
Forbes
Fri, 01/25/13 - 11:05 am
CETP inhibitors
Merck
Anacetrapib
Torcetrapib
Pfizer
Roche
dalceptrapib
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech
Wed, 08/29/12 - 12:21 pm
Big Pharma
Lipitor
Anacetrapib
Merck
Plavix
Pfizer
Bristol-Myers Squibb
PCSK9 inhibitor
Sanofi
Regeneron
darapladib
Roche
GSK
Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About
Seeking Alpha
Sun, 11/20/11 - 12:14 pm
CETP inhibitors
Merck
Roche
Eli Lilly
Anacetrapib
dalcetrapib
evacetrapib
Roche expects $10 billion sales for HDL drug
Yahoo/Reuters
Mon, 09/26/11 - 11:31 am
Roche
HDL therapy
Merck
dalcetrapib
Anacetrapib
Will Merck Succeed Where Pfizer Did Not?
Seeking Alpha
Thu, 02/10/11 - 09:11 am
Pfizer
Merck
CETP inhibitors
Anacetrapib
Torcetrapib
Merck’s Cholesterol Drug May Become Catalyst for Future Growth
Seeking Alpha
Wed, 12/29/10 - 10:42 am
Merck
Anacetrapib
cholesterol
Merck's CETP Compound Sails Ahead Into Potentially Murky Waters
Seeking Alpha
Sat, 11/20/10 - 12:20 pm
Merck
CETP inhibitors
Anacetrapib
cholesterol
Cholesterol drug could be financial boon for Merck
Yahoo/AP
Wed, 11/17/10 - 06:24 pm
Merck
cholesterol
Anacetrapib
Pfizer

Pages